This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825673.
“HIV-TB-HCV: EU-Russia cooperation results”
The “HIV-TB-HCV: EU-Russia cooperation results” online conference has been held successfully on June 15th 2021.
The main objective was to present and discuss outcomes and findings from CARE Common Action and other projects and initiatives in the frame of recent collaborative research in the WHO European Region.
It has seen the participation of CARE, ARREST-TB, CARE External Scientific Advisory Board, CARE External Ethics Review Board, Russian experts, NDPHS, Russian Ministry of Health, Russian Ministry of Science and Higher Education, EC, EU Delegation to the Russian Federation.
Here you can find the Programme.
The video recordings:
-
Welcome & TB Research Session.
-
HIV & HCV Research Session.
-
Final session & Panel discussion.
The playlist is available here.
The presentations:
-
Novel diagnostic approaches in TB and MDR-TB and biomarkers of treatment response: results from the CARE project and future perspectives (Drobniewski). View
-
Genotypic prediction of tuberculosis drug resistance and implementation of effective MDR-TB management: Results from the CARE project and future perspectives (Heyckendorf). View
-
Characterization of mutations in Mycobacterium tuberculosis strains associated with drug resistance based on genome-wide sequencing data (Chernyaeva et al.). View
-
HIV molecular epidemiology and new treatment strategies in Russia and Eastern Europe: results of the research in CARE (Antonova et al.). View